Search

Your search keyword '"Fedewa, Stacey A."' showing total 17 results
Start Over Author "Fedewa, Stacey A." Journal cancer
17 results on '"Fedewa, Stacey A."'

10. Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics

Author

Negoita, Serban, Feuer, Eric J., Mariotto, Angela, Cronin, Kathleen A., Petkov, Valentina I., Hussey, Sarah K., Benard, Vicki, Henley, S. Jane, Anderson, Robert N., Fedewa, Stacey, Sherman, Recinda L., Kohler, Betsy A., Dearmon, Barbara J., Lake, Andrew J., Ma, Jiemin, Richardson, Lisa C., Jemal, Ahmedin, and Penberthy, Lynne

Subjects
trends, Male, Epidemiology, Advisory Committees, Discipline, Age Distribution, Cost of Illness, Preventive Health Services, Prevalence, Humans, Mass Screening, Gleason score, Mortality, Early Detection of Cancer, Aged, Neoplasm Staging, Incidence, Prostatic Neoplasms, Original Articles, Middle Aged, Prostate-Specific Antigen, prostate cancer, United States, Original Article, prostate‐specific antigen, Neoplasm Grading, SEER Program
Abstract

BACKGROUND Temporal trends in prostate cancer incidence and death rates have been attributed to changing patterns of screening and improved treatment (mortality only), among other factors. This study evaluated contemporary national‐level trends and their relations with prostate‐specific antigen (PSA) testing prevalence and explored trends in incidence according to disease characteristics with stage‐specific, delay‐adjusted rates. METHODS Joinpoint regression was used to examine changes in delay‐adjusted prostate cancer incidence rates from population‐based US cancer registries from 2000 to 2014 by age categories, race, and disease characteristics, including stage, PSA, Gleason score, and clinical extension. In addition, the analysis included trends for prostate cancer mortality between 1975 and 2015 by race and the estimation of PSA testing prevalence between 1987 and 2005. The annual percent change was calculated for periods defined by significant trend change points. RESULTS For all age groups, overall prostate cancer incidence rates declined approximately 6.5% per year from 2007. However, the incidence of distant‐stage disease increased from 2010 to 2014. The incidence of disease according to higher PSA levels or Gleason scores at diagnosis did not increase. After years of significant decline (from 1993 to 2013), the overall prostate cancer mortality trend stabilized from 2013 to 2015. CONCLUSIONS After a decline in PSA test usage, there has been an increased burden of late‐stage disease, and the decline in prostate cancer mortality has leveled off. Cancer 2018;124:2801‐2814. © 2018 American Cancer Society, For the first time, the US cancer surveillance community has performed an analysis of long‐term trends in the incidence of prostate cancer by stage with delay‐adjusted rates. According to nationwide cancer registry and vital registration data, prostate cancer incidence rates for distant‐stage disease have increased and mortality rates for all stages combined have leveled off in the United States since the US Preventive Services Task Force recommendations against prostate‐specific antigen–based screening.See also pages 2785‐800 and 2690‐2.

Published
2018

16. Unemployment and cancer screening: Baseline estimates to inform health care delivery in the context of COVID-19 economic distress.

Author

Fedewa SA, Yabroff KR, Bandi P, Smith RA, Nargis N, Zheng Z, Drope J, and Jemal A

Subjects
Adult, Health Services Accessibility, Humans, United States epidemiology, COVID-19, Early Detection of Cancer statistics & numerical data, Insurance, Health, Unemployment
Abstract

Background: During the coronavirus disease 2019 pandemic, US unemployment rates rose to historic highs, and they remain nearly double those of prepandemic levels. Employers are the most common source of health insurance among nonelderly adults. Thus, job loss may lead to a loss of health insurance and reduce access to cancer screening. This study examined associations between unemployment, health insurance, and cancer screening to inform the pandemic's potential impacts on early cancer detection., Methods: Up-to-date and past-year breast, cervical, colorectal, and prostate cancer screening prevalences were computed for nonelderly respondents (aged <65 years) with 2000-2018 National Health Interview Survey data. Multivariable logistic regression models with marginal probabilities were used to estimate unemployed-versus-employed unadjusted and adjusted prevalence ratios., Results: Unemployed adults (2000-2018) were 4 times more likely to lack insurance than employed adults (41.4% vs 10.0%; P < .001). Unemployed adults had a significantly lower up-to-date prevalence of screening for cervical cancer (78.5% vs 86.2%; P < .001), breast cancer (67.8% vs 77.5%; P < .001), colorectal cancer (41.9 vs 48.5%; P < .001), and prostate cancer (25.4% vs 36.4%; P < .001). These differences were eliminated after accounting for health insurance coverage., Conclusions: Unemployment was adversely associated with up-to-date cancer screening, and this was fully explained by a lack of health insurance. Ensuring the continuation of health insurance coverage after job loss may mitigate the pandemic's economic distress and future economic downturns' impact on cancer screening., (© 2021 American Cancer Society.)

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results